Plasma Nerve Growth Factor (NGF) and inflammatory cytokines (IL-6 and MCP-1) in young and adult subjects with Down Syndrome: An interesting pathway

Massimiliano M. Corsi, Giada Dogliotti, Francesca Pedroni, Elisa Palazzi, Paolo Magni, Martina Chiappelli, Federico Licastro

Research output: Contribution to journalArticlepeer-review

Abstract

Objective: Down's syndrome (DS) is the most frequent chromosomal aberration in men and it is invariably associated with mental retardation. Material and Methods: Plasma levels of nerve growth factor (NGF), interleukin-6 (IL-6), and monocyte chemoattractant protein-1 (MCP-1) from non demented DS subjects of three different age-cohorts (2-14 years; 20-50 yrs; > 60 yrs) and healthy controls were measured. No clinical and sub-clinical inflammation was apparent in DS patients. Results: Plasma levels of NGF were higher in children, adult and old DS subjects than in controls. However, a significant age-related decrease of NGF levels was present in DS subjects. Serum levels of IL-6 and MCP-1 were also increased in DS children and adults, but not in older DS patients. Conclusions: High levels of circulating NGF might protect DS from clinical complications of atherosclerosis. However, the striking decrement of peripheral NGF levels with advancing age may predispose DS to clinical manifestation of dementia after adulthood.

Original languageEnglish
Pages (from-to)773-778
Number of pages6
JournalNeuroendocrinology Letters
Volume27
Issue number6
Publication statusPublished - Dec 2006

Keywords

  • Down's syndrome
  • Interleukin-6
  • Monocyte chemoattractant protein-1
  • Nerve growth factor

ASJC Scopus subject areas

  • Endocrinology
  • Neuroscience(all)

Fingerprint

Dive into the research topics of 'Plasma Nerve Growth Factor (NGF) and inflammatory cytokines (IL-6 and MCP-1) in young and adult subjects with Down Syndrome: An interesting pathway'. Together they form a unique fingerprint.

Cite this